CALGARY, Feb. 8, 2013 /CNW/ - Epicore BioNetworks Inc. announces that it
has granted stock options to non-executive directors of the company.
The number of options granted is 150,000, which is equivalent to 0.6%
of Epicore's issued common stock. Under the terms of the Epicore Stock
Option Plan, options may be issued from time to time in any amount up
to a maximum of 4,704,246 Epicore common shares. These options have an
exercise price of Cdn $0.21 and expire in five years. The grant to
directors follows Company board compensation policy.
Epicore BioNetworks Inc. is a leading producer of environmental
biotechnology and animal nutrition products. It manufactures in the
USA and markets worldwide to a variety of industries to reduce
environmental pollution and increase operational productivity.
Epicore BioNetworks Inc. is a public corporation with a registered
office in Calgary, Alberta, Canada and with shares listed on the TSX
Venture Exchange (symbol EBN). [Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the policies
of the TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.]
SOURCE: Epicore BioNetworks Inc.
For further information:
Mr. William P. Long (Chief Executive Officer)
USA. Tel: 609-267-9118,